IP Library Granted Patent US 9,255,249
Granted Patent B2
US 9,255,249 · App. 11/650,723 · Granted Feb 9, 2016

Isolation and purification of hematopoietic stem cells from post-liposuction lipoaspirates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,255,249
App. No.
11/650,723
Granted
Feb 9, 2016
Kind
B2
Abstract

The present invention relates to a method of isolating hematopoietic stem cells from adipose tissue. The method yields a notably high number of CD34 + , ALDH br and/or ABCG2-expressing cells, comprising hematopoietic stem cells, permitting the use of the cells with no or minimal expansion.

Claims (13)

1. A method for isolating a CD34 + cell, the method comprising:

obtaining adipose tissue,

preparing a stromal vascular fraction (SVF) from the adipose tissue;

incubating SVF cells in a stromal cell media in a cell culture apparatus for a time suitable for the culture of cells in vitro to allow the cells to adhere to the culture apparatus; separating nonadherent cells in the SVF from adherent cells in the SVF; and

identifying CD34+ cells in the non-adherent cell population, and isolating the CD34 + cells from the CD34− nonadherent cells,

wherein at least about 40% of the non-adherent cells are CD34 + cells.

2. The method of claim 1 , wherein the CD34 + cell is isolated in the ratio of at least about 1×10 7 CD34 + cells isolated per about 100 ml of adipose tissue.

3. The method of claim 1 , wherein the obtaining step comprises lipoaspiration.

4. The method of claim 1 , wherein the adipose tissue is human.

5. The method of claim 1 , wherein the CD34 + cell is selected from the group consisting of a CD34 + SSC lo cell, a CD34 + CD45 + cell, a CD34 hi CD38 − CD4 − cell, a CD34 + CD38 − CD41 − SSC lo , a CD34 lo CD45 − cell, a CD34 lo CD45 + cell, a CD34 + ALDH br cell and a CD34 + ALDH br SSC lo cell.

6. The method of claim 1 , further comprising the step of isolating a CD34 hi cell or a CD34 lo cell.

7. The method of claim 1 , wherein the CD34 + cell is selected from the group consisting a colony-forming unit granulocyte macrophage (CFU-GM), a burst-forming unit erythrocyte (BFU-E) and a colony-forming unit granulocyte erythrocyte macrophage megakaryocyte (CFU-GEMM).

8. The method of claim 1 , further comprising harvesting the adherent cells, thereby harvesting adipose tissue-derived stromal cells.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 6, 2016
From: VENCORE SOLUTIONS LLLC
To: COGNATE BIOSERVICES, INC.
Reel/Frame 038202/0253 →
RELEASE OF SECURITY INTEREST Recorded Apr 6, 2016
From: VENCORE SOLUTIONS LLC
To: COGNATE BIOSERVICES, INC.
Reel/Frame 038208/0830 →
LIEN Recorded Apr 30, 2009
From: ARTECEL, INC.; COGNATE BIOSERVICES, INC.; THERADIGM, INC.
To: SEED INTELLECTUAL PROPERTY LAW GROUP PLLC
Reel/Frame 022619/0065 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2009
From: ARTECEL, INC.
To: COGNATE BIOSERVICES, INC.
Reel/Frame 022313/0075 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2008
From: COGNATE BIOSERVICES, INC.
To: ARTECEL, INC.
Reel/Frame 021028/0997 →
SECURITY INTEREST Recorded Apr 16, 2008
From: COGNATE BIOSERVICES, INC.
To: VENCORE SOWTIONS LLC
Reel/Frame 020823/0230 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2007
From: MITCHELL II, JAMES B.
To: COGNATE BIOSERVICES, INC.
Reel/Frame 019693/0654 →